F.D.A. Plan on Medical Articles Takes More Heat - New York Times - The Diigo Meta page

• 21 Apr 08
  

  Sally Church

  Few Doctors have the time to write medical articles so the timing of the uproar with Merck-SP's Vytorin news is somewhat suspicious.

  business FDA FDAMA pharmaceuticals biotechnology strategy companies

Would you like to comment?

Join Diigo for a free account, or sign in if you are already a member.